ADAPTIVE BIOTECHNOLOGIES (ADPT) Stock Institutional Owners
ADAPTIVE BIOTECHNOLOGIES (ADPT) is held by 3 institutional investors with a total value of $539.75M. This comprehensive analysis highlights the top institutional holders led by Viking Global Investors, ARK Invest, Polen Capital Management, and others, who collectively account for nearly 100% of the total institutional ownership.Viking Global Investors remains the largest institutional holder with a position worth $487.10M. Explore insights into ownership patterns, position sizes, and portfolio allocations to understand institutional investment strategies and market sentiment.
Explore more:
- ADAPTIVE BIOTECHNOLOGIES (ADPT) stock institutional trading activity
- ADAPTIVE BIOTECHNOLOGIES (ADPT) stock insider trading activity
- Stock rankings
| Name | Investor/Manager | Portfolio % | Quantity | Reported Balance |
|---|---|---|---|---|
| Viking Global Investors | Ole Andreas Halvorsen | 1.29% | 29,993,708 | $487,097,818 |
| ARK Invest | Cathie Wood | 0.28% | 3,165,636 | $47,357,912 |
| Polen Capital Management | David M. Polen | 0.02% | 325,767 | $5,290,456 |
Frequently asked questions about ADPT
Who owns the most ADPT stock?
The largest holders of ADPT are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for ADAPTIVE BIOTECHNOLOGIES (ADPT).
Is ADPT widely held by superinvestors?
Many widely followed stocks like ADPT appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly ADPT is represented among the institutional managers we track.